Search

Your search keyword '"Boutoleau-Bretonnière, Claire"' showing total 12 results
Start Over Author "Boutoleau-Bretonnière, Claire" Journal journal of alzheimer's disease
12 results on '"Boutoleau-Bretonnière, Claire"'

2. Improving the Diagnosis of the Frontal Variant of Alzheimer’s Disease with the DAPHNE Scale

Author

Lehingue, Elsa, primary, Gueniat, Julien, additional, Jourdaa, Sandra, additional, Hardouin, Jean BenoÎt, additional, Pallardy, Amandine, additional, Courtemanche, Hélène, additional, Rocher, Laëtitia, additional, Etcharry-Bouyx, Frédérique, additional, Auriacombe, Sophie, additional, Mollion, Hélène, additional, Formaglio, Maité, additional, Rouaud, Olivier, additional, Bretonnière, Cédric, additional, Thomas-Antérion, Catherine, additional, and Boutoleau-Bretonnière, Claire, additional

Published
2021
Full Text
View/download PDF

4. The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer’s Disease During the COVID-19 Crisis

Author

Boutoleau-Bretonnière, Claire, primary, Pouclet-Courtemanche, Hélene, additional, Gillet, Aurelie, additional, Bernard, Amelie, additional, Deruet, Anne Laure, additional, Gouraud, Ines, additional, Mazoue, Aurelien, additional, Lamy, Estelle, additional, Rocher, Laetitia, additional, Kapogiannis, Dimitrios, additional, and El Haj, Mohamad, additional

Published
2020
Full Text
View/download PDF

5. Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Author

Magnin, Eloi, Démonet, Jean-François, Wallon, David, Dumurgier, Julien, Troussière, Anne-Cécile, Jager, Alain, Duron, Emmanuelle, Gabelle, Audrey, de La Sayette, Vincent, Volpe-Gillot, Lisette, Tio, Gregory, Evain, Sarah, Boutoleau-Bretonnière, Claire, Enderle, Adeline, Mouton-Liger, François, Robert, Philippe, Hannequin, Didier, Pasquier, Florence, Hugon, Jacques, Paquet, Claire, Collaborators, Eplm, Centre Mémoire de Ressources et de Recherche [CHRU de Besançon] (CMRR), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques [CHRU de Besançon], Service de neurologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Génétique du cancer et des maladies neuropsychiatriques (GMFC), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Mémoire de Ressources et de Recherche Paris Nord Ile-de-France (CMRR), Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Biomarqueurs CArdioNeuroVASCulaires (BioCANVAS), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Troubles cognitifs dégénératifs et vasculaires - U 1171 (TCDV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Mémoire de Ressources et de Recherche - CMRR [CHRU Lille], Centre de Neurologie [Thionville], Centre hospitalier régional Metz-Thionville (CHR Metz-Thionville), Centre de Mémoire de Ressources et de Recherche [Paris Broca], AP-HP - Hôpital Broca [Paris], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cellules souches normales et cancéreuses, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Groupe Hospitalier Paris Saint Joseph, Centre Mémoire de Ressources et de Recherche [CHU de Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Mémoire de Ressources et de Recherche [Nice] (CMRR Nice), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre Hospitalier Universitaire de Nice (CHU Nice)-Université Côte d'Azur (UCA), Cognition Behaviour Technology (CobTek), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre Hospitalier Universitaire de Nice (CHU Nice)-Institut Claude Pompidou [Nice] (ICP - Nice)-Université Côte d'Azur (UCA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 1 (UM1)-Université de Montpellier (UM), Université Côte d'Azur (UCA)-Centre Hospitalier Universitaire de Nice (CHU Nice)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), Université Côte d'Azur (UCA)-Université Nice Sophia Antipolis (... - 2019) (UNS), and COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre Hospitalier Universitaire de Nice (CHU Nice)-Institut Claude Pompidou [Nice] (ICP - Nice)

Subjects
Male, 0301 basic medicine, Databases, Factual, Disease, frontotemporal dementia, Cohort Studies, Tertiary Care Centers, Primary progressive aphasia, 0302 clinical medicine, Epidemiology, gender, Medicine, Prospective Studies, Prospective cohort study, Cognitive reserve, Aged, 80 and over, education.field_of_study, General Neuroscience, General Medicine, Middle Aged, respiratory system, 3. Good health, Psychiatry and Mental health, Clinical Psychology, epidemiology, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Female, France, Alzheimer’s disease, Cognitive psychology, Frontotemporal dementia, medicine.medical_specialty, Population, 03 medical and health sciences, Alzheimer Disease, Internal medicine, Humans, cerebrospinal fluid biomarkers, education, Secondary Care Centers, Aged, Retrospective Studies, business.industry, Retrospective cohort study, medicine.disease, Aphasia, Primary Progressive, 030104 developmental biology, primary progressive aphasia, Geriatrics and Gerontology, business, 030217 neurology & neurosurgery
Abstract

BACKGROUND: Few demographical data about primary progressive aphasia (PPA) are available, and most knowledge regarding PPA is based on tertiary centers' results. OBJECTIVE: Our aims were to describe demographical characteristics of the PPA population in a large sample of PPA patients from the network of French Alzheimer plan memory centers (Sample 1), and to describe the stratification of cerebrospinal fluid (CSF) biomarkers in two different samples of PPA patients (Samples 2 and 3). METHODS: All registered PPA patients in the French Alzheimer's disease (AD) databank (Sample 1: n = 2,035) and a subsample (Sample 2: n = 65) derived from a multicentric prospective cohort with CSF biomarker analysis were analyzed. A multicentric retrospective cohort from language expert tertiary centers (Sample 3: n = 97) with CSF biomarker analysis was added. Sample 3 was added to replicate the CSF results of the Sample 2 and to evaluate repartition of AD pathology in the three variant of PPA according to the latest classification. RESULTS: Non-Fluent/Agrammatic, Logopenic, and Unclassifiable PPA patients (NF/A-Logo-Unclass PPA) were older and more frequent than Semantic PPA patients (2.2 versus 0.8/100,000 inhabitants; p

Published
2016
Full Text
View/download PDF

7. Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations

Author

Luis, Elkin, primary, Ortiz, Alexandra, additional, Eudave, Luis, additional, Ortega-Cubero, Sara, additional, Borroni, Barbara, additional, van der Zee, Julie, additional, Gazzina, Stefano, additional, Caroppo, Paola, additional, Rubino, Elisa, additional, D’Agata, Federico, additional, Le Ber, Isabelle, additional, Santana, Isabel, additional, Cunha, Gil, additional, Almeida, Maria R., additional, Boutoleau-Bretonnière, Claire, additional, Hannequin, Didier, additional, Wallon, David, additional, Rainero, Innocenzo, additional, Galimberti, Daniela, additional, Van Broeckhoven, Christine, additional, Pastor, Maria A., additional, and Pastor, Pau, additional

Published
2016
Full Text
View/download PDF

8. A Phenotype of Atypical Apraxia of Speech in a Family Carrying SQSTM1 Mutation

Author

Boutoleau-Bretonnière, Claire, primary, Camuzat, Agnès, additional, Le Ber, Isabelle, additional, Bouya-Ahmed, Kawtar, additional, Guerreiro, Rita, additional, Deruet, Anne-Laure, additional, Evrard, Christelle, additional, Bras, José, additional, Lamy, Estelle, additional, Auffray-Calvier, Elisabeth, additional, Pallardy, Amandine, additional, Hardy, John, additional, Brice, Alexis, additional, Derkinderen, Pascal, additional, and Vercelletto, Martine, additional

Published
2014
Full Text
View/download PDF

9. Value of Neuropsychological Testing, Imaging, and CSF Biomarkers for the Differential Diagnosis and Prognosis of Clinically Ambiguous Dementia

Author

Boutoleau-Bretonnière, Claire, primary, Lebouvier, Thibaud, additional, Delaroche, Odile, additional, Lamy, Estelle, additional, Evrard, Christelle, additional, Charriau, Tiphaine, additional, Bretonnière, Cédric, additional, Damier, Philippe, additional, Derkinderen, Pascal, additional, and Vercelletto, Martine, additional

Published
2012
Full Text
View/download PDF

10. Memantine in Behavioral Variant Frontotemporal Dementia: Negative Results

Author

Vercelletto, Martine, primary, Boutoleau-Bretonnière, Claire, additional, Volteau, Christelle, additional, Puel, Michèle, additional, Auriacombe, Sophie, additional, Sarazin, Marie, additional, Michel, Bernard-François, additional, Couratier, Philippe, additional, Thomas-Antérion, Catherine, additional, Verpillat, Patrice, additional, Gabelle, Audrey, additional, Golfier, Véronique, additional, Cerato, Evelyne, additional, and Lacomblez, Lucette, additional

Published
2011
Full Text
View/download PDF

11. A Phenotype of Atypical Apraxia of Speech in a Family Carrying SQSTM1 Mutation.

Author

Boutoleau-Bretonnière, Claire, Camuzat, Agnès, Le Ber, Isabelle, Bouya-Ahmed, Kawtar, Guerreiro, Rita, Deruet, Anne-Laure, Evrard, Christelle, Bras, José, Lamy, Estelle, Auffray-Calvier, Elisabeth, Pallardy, Amandine, Hardy, John, Brice, Alexis, Derkinderen, Pascal, and Vercelletto, Martine

Subjects
*GENETIC mutation, *FRONTOTEMPORAL dementia, *HUMAN phenotype, *SPEECH apraxia, *BEHAVIOR disorders
Abstract

SQSTM1 mutations, coding for the p62 protein, were identified as a monogenic cause of Paget disease of bone and of amyotrophic lateral sclerosis. More recently, SQSTM1 mutations were identified in few families with frontotemporal dementia. We report a new family carrying SQSTM1 mutation and presenting with a clinical phenotype of speech apraxia or atypical behavioral disorders, associated with early visuo-contructional deficits. This study further supports the implication of SQSTM1 in frontotemporal dementia, and enlarges the phenotypic spectrum associated with SQSTM1 mutations. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

12. The French Series of Autosomal Dominant Early Onset Alzheimer's Disease Cases: Mutation Spectrum and Cerebrospinal Fluid Biomarkers.

Author

Wallon, David, Rousseau, Stéphane, Rovelet-Lecrux, Anne, Quillard-Muraine, Muriel, Guyant-Maréchal, Lucie, Martinaud, Olivier, Pariente, Jérémie, Puel, Michèle, Rollin-Sillaire, Adeline, Pasquier, Florence, Le Ber, Isabelle, Sarazin, Marie, Croisile, Bernard, Boutoleau-Bretonnière, Claire, Thomas-Antérion, Catherine, Paquet, Claire, Moreaud, Olivier, Gabelle, Audrey, Sellal, François, and Sauvée, Mathilde

Subjects
ALZHEIMER'S disease, CEREBROSPINAL fluid, BIOMARKERS, PATIENTS, GENETIC determinism
Abstract

We describe 56 novel autosomal dominant early-onset Alzheimer disease (ADEOAD) families with PSEN1, PSEN2, and AβPP mutations or duplications, raising the total of families with mutations on known genes to 111 (74 PSEN1, 8 PSEN2, 16 AβPP, and 13 AβPP duplications) in the French series. In 33 additional families (23% of the series), the genetic determinism remained uncharacterized after this screening. Cerebrospinal fluid (CSF) biomarker levels were obtained for patients of 58 families (42 with known mutations and 16 without genetic characterization). CSF biomarkers profile was consistent with an AD diagnosis in 90% of families carrying mutations on known genes. In families without mutation, CSF biomarkers were consistent with AD diagnosis in 14/16 cases. Overall, these results support further genetic heterogeneity in the determinism of ADEOAD and suggest that other major genes remain to be characterized. [ABSTRACT FROM AUTHOR]

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results